DK1581224T3 - Tiotropiumholdig lægemiddelsammensætning til inhalation - Google Patents

Tiotropiumholdig lægemiddelsammensætning til inhalation

Info

Publication number
DK1581224T3
DK1581224T3 DK03779979T DK03779979T DK1581224T3 DK 1581224 T3 DK1581224 T3 DK 1581224T3 DK 03779979 T DK03779979 T DK 03779979T DK 03779979 T DK03779979 T DK 03779979T DK 1581224 T3 DK1581224 T3 DK 1581224T3
Authority
DK
Denmark
Prior art keywords
tiotropium
inhalation
drug composition
containing drug
several
Prior art date
Application number
DK03779979T
Other languages
English (en)
Inventor
Michael P Pieper
Ingo Konetzki
Michel Pairet
Christopher John Montagu Meade
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Application granted granted Critical
Publication of DK1581224T3 publication Critical patent/DK1581224T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4706—4-Aminoquinolines; 8-Aminoquinolines, e.g. chloroquine, primaquine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK03779979T 2002-11-29 2003-11-19 Tiotropiumholdig lægemiddelsammensætning til inhalation DK1581224T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10256080A DE10256080A1 (de) 2002-11-29 2002-11-29 Tiotropiumhaltige Arzneimittelkombination für die Inhalation
PCT/EP2003/012913 WO2004050093A1 (de) 2002-11-29 2003-11-19 Tiotropiumhaltige arzneimittelkombination für die inhalation

Publications (1)

Publication Number Publication Date
DK1581224T3 true DK1581224T3 (da) 2008-03-25

Family

ID=32318866

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03779979T DK1581224T3 (da) 2002-11-29 2003-11-19 Tiotropiumholdig lægemiddelsammensætning til inhalation

Country Status (9)

Country Link
EP (1) EP1581224B1 (da)
JP (1) JP4850415B2 (da)
AT (1) ATE384531T1 (da)
AU (1) AU2003288107A1 (da)
CA (1) CA2507656C (da)
DE (2) DE10256080A1 (da)
DK (1) DK1581224T3 (da)
ES (1) ES2298597T3 (da)
WO (1) WO2004050093A1 (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1938822A1 (en) * 2006-12-21 2008-07-02 Novartis AG Combination therapy for the treatment of airways disease
CN103096897A (zh) * 2010-07-16 2013-05-08 希普拉有限公司 包含r(+)布地奈德和一种或多种支气管扩张剂的药物组合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9913083D0 (en) * 1999-06-04 1999-08-04 Novartis Ag Organic compounds
GB0009583D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Respiratory formulations
GB0009606D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Therapeutic combinations
DE10056104A1 (de) * 2000-11-13 2002-05-23 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Tiotropiumsalzen und Salzen des Salmeterols

Also Published As

Publication number Publication date
JP4850415B2 (ja) 2012-01-11
JP2006509776A (ja) 2006-03-23
CA2507656C (en) 2011-07-12
DE50309096D1 (de) 2008-03-13
EP1581224B1 (de) 2008-01-23
DE10256080A1 (de) 2004-06-17
AU2003288107A1 (en) 2004-06-23
WO2004050093A1 (de) 2004-06-17
ATE384531T1 (de) 2008-02-15
ES2298597T3 (es) 2008-05-16
EP1581224A1 (de) 2005-10-05
CA2507656A1 (en) 2004-06-17

Similar Documents

Publication Publication Date Title
UA85708C2 (ru) Лекарственные комбинации, содержащие бензоксазины, для лечения заболеваний дыхательных путей
WO2004037807A3 (en) Medicinal arylethanolamine compounds
DE60318193D1 (en) Phenethanolaminderivate
ATE361077T1 (de) Indanylderivate zur behandlung von atemwegserkrankungen
MY134222A (en) NEW MEDICAMENT COMPOSITIONS BASED ON ANTICHOLINERGICALLY-EFFECTIVE COMPOUNDS AND ß-MIMETICS
GEP20043269B (en) Purine Derivatives, Method for Their Production and Composition Containing the Same
NO20032111L (no) Nye medikamentblandinger basert pa tiotropium-salter og pa salmeterol-salter
SE0401345D0 (sv) Therapeutic compounds: Pyridine as scaffold
HRP20040944B1 (en) Medicaments containing betamimetic drugs and a novel anticholinesterase drug
TNSN04203A1 (en) Benzoxazinone-derived compounds, their preparation and use as medicaments
WO2002088100A3 (de) Deuterierte 3-piperidinopropiophenone sowie diese verbindungen enthaltende arzneimittel
WO2003087049A3 (de) Arzneimittelkombinationen enthaltend heterocyclische verbindungen und ein neues anticholinergikum
EA200600854A1 (ru) Новые соли тиотропия, способ их получения, а также содержащие их лекарственные композиции
MXPA06013221A (es) Formulaciones en polvo para la inhalacion, las cuales contienen beta-agonistas enantiomericamente puros.
SG137859A1 (en) Method for producing tiotropium salts, tiotropium salts and pharmaceutical formulations, containing the same
MXPA04002401A (es) Nuevos medicamentos para inhalacion.
BR0307703A (pt) Composições de medicamentos na base de agentes anticolinérgicos e inibidores de quinase de egfr
DK1581224T3 (da) Tiotropiumholdig lægemiddelsammensætning til inhalation
DE602004019096D1 (de) Medikamente zur inhalation mit betamimetika und einem anticholinergikum
MY141724A (en) Medicaments containing betamimetic drugs and a novel anticholinesterase drug
TW200612914A (en) Novel oxidized thioether derivatives, their manufacture and use as pharmaceutical agents
MXPA05013717A (es) Derivados de acido 2-etoxi-2-fenilpropionico para el tratamiento de trastornos de lipido.
SE0301904D0 (sv) Novel imidazopyridine compound II with therapeutic effect
ATE301997T1 (de) Antivirale therapie
WO2005007134A8 (de) Pulverformulierungen für die inhalation enthaltend ein neues anticholinergikum